Predict Ends Buyback Early to Clear Path for New Treasury Share Plan

An announcement from Predict S.P.A. Class B ( (IT:PRE) ) is now available.

Predict S.p.A. has terminated early its existing share buyback program, originally approved in April 2025, in order to pave the way for a new treasury share purchase and disposal plan before the prior authorization’s 18‑month term expired. The company had launched the program in November 2025 with a potential ceiling of 20% of share capital and a maximum outlay of €700,000, but ultimately repurchased 48,000 shares, equal to about 0.618% of capital, for roughly €38,235.

The early closure consolidates a modest treasury stake while giving the board flexibility to redesign its capital management tools, including future liquidity support, incentive schemes and potential use of shares in extraordinary transactions. For investors, the move signals continued active management of the company’s equity structure on Euronext Growth Milan, albeit with limited immediate impact given the small volume of shares acquired under the revoked plan.

The most recent analyst rating on (IT:PRE) stock is a Buy with a EUR1.40 price target. To see the full list of analyst forecasts on Predict S.P.A. Class B stock, see the IT:PRE Stock Forecast page.

More about Predict S.P.A. Class B

Predict S.p.A. is an Italian med-tech SME focused on in vivo diagnostics, distributing ultrasound and radiology equipment while developing advanced solutions in breath analysis and digital healthcare. Through four business units, it offers imaging support, the Mistral breath-analysis platform, and augmented-reality and robotics tools such as Aphel, Optip and Optip Stage, underpinned by partnerships with leading hospitals and research institutes.

Average Trading Volume: 24,658

Technical Sentiment Signal: Sell

Current Market Cap: €5.64M

Find detailed analytics on PRE stock on TipRanks’ Stock Analysis page.